Dance and Movement Therapy in Outpatient Oncology - Influences Dance and Movement therapy the resilience and self-efficacy of children and adolescents in outpatient oncology?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00036239

Enrollment

Registered

2025-02-21

Start date

2025-02-13

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children and adolescents with tumor disease

Interventions

Group 1: Children and adolescents All participants receive therapeutic support over a period of three weeks, with two sessions per week, each lasting approximately 30 minutes. Sessions are designed t

Eligibility

Sex/Gender

All

Age

4 Years to 17 Years

Inclusion criteria

Inclusion criteria: All children and young people between the ages of 4 and 17 who are treated at the West German Proton Therapy Center.

Exclusion criteria

Exclusion criteria: A treatment time of less than 20 days and a contraindication to physical activity.

Design outcomes

Primary

Measure	Time frame
The primary aim of the study is to evaluate the effects of Dance and Movement Therapy on resilience and self-efficacy in pediatric oncology patients. Questionnaire: Child and Youth Resilience Measure (CYRM-28) (Panter-Brick et al., 2017) Questionnaire: Creative Self-Efficacy Scale for Children and Adolescents (CASES) (Valquaresma, Coimbra & Costa, 2022) Questionnaire: General Self-Efficacy Scale (Schwarzer & Jerusalem, 2010)	—

Measure

Time frame

The primary aim of the study is to evaluate the effects of Dance and Movement Therapy on resilience and self-efficacy in pediatric oncology patients. Questionnaire: Child and Youth Resilience Measure (CYRM-28) (Panter-Brick et al., 2017) Questionnaire: Creative Self-Efficacy Scale for Children and Adolescents (CASES) (Valquaresma, Coimbra & Costa, 2022) Questionnaire: General Self-Efficacy Scale (Schwarzer & Jerusalem, 2010)

—

Secondary

Measure	Time frame
The secondary aim of the study is to assess changes in symptom burden (e.g. pain, fatigue) in children and adolescents during radiotherapy treatment using the Memorial Symptom Assessment Scale (MSAS).	—

Countries

Germany

Contacts

Public ContactSusann Kobus

Universitätsklinikum Essen

susann.kobus@uk-essen.de004920172386267

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026